Loading
A phase 3 trial of Antineoplastons in Glioma & glioblastoma, run by Burzynski Research Institute, not yet recruiting.
Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma is a phase 3 interventional study registered as NCT02887040 by Burzynski Research Institute, with 92 participants planned, started 2025-10-01 and due to reach its primary completion in 2026-06. Interventions recorded: Radiation, Atengenal, Astugenal. Conditions recorded: Brain Stem Glioma.
Linked to the technology Antineoplastons because the registry's title names it ("antineoplastons") and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
Shares Antineoplastons (Burzynski clinic), Glioma & glioblastoma and the tag pipeline.
Shares Antineoplastons (Burzynski clinic) and the tag pipeline.
Shares Glioma & glioblastoma and the tag pipeline.
Shares Glioma & glioblastoma and the tag pipeline.
Shares Glioma & glioblastoma and the tag pipeline.
Shares Glioma & glioblastoma and the tag pipeline.
Shares Glioma & glioblastoma and the tag pipeline.
Shares Glioma & glioblastoma and the tag pipeline.